| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Edward J Rapp is Director at XOS and has filed Form 4s across 2 companies. Edward J Rapp's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.8M at current prices.
Historically, Edward J Rapp's trades have earned a below-average insider score of 21/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -71.3%.
The biggest single holding is ABBV (~$13.3M) as Director. Net of sales, the ABBV filings show accumulation of 15,388 shares.
Edward J Rapp has 84 Form 4 filings on record from May 2015 to October 2026, across 2 companies: Director at Xos (XOS), 2021–2026; Director at AbbVie (ABBV), 2015–2026.
The 90 reported transactions were 44 option or other derivative awards, 37 stock awards, 7 open-market purchases and 2 gifts.
Counted by filing, the open-market trades come to 7 purchases worth about $1.8M and no sales.
The largest open-market purchase was 7,500 shares of ABBV at an average $67.30 on June 26, 2019, about $505K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | XOS Xos, Inc. | Director | Buy | 300,000 | $0.69 | $207,000.00 | +140.6% | +19.9% | -55.5% | |
| Nov 18, 2021 | XOS Xos, Inc. | Director | Buy | 100,000 | $4.27 | $426,820.00 | +42.5% | -43.9% | -80.5% | |
| Sep 1, 2021 | XOS Xos, Inc. | Director | Buy | 5,000 | $6.65 | $33,250.00 | +2.2% | -39.9% | -78.1% | |
| Mar 3, 2020 | ABBV Abbvie Inc. | Director | Buy | 2,875 | $87.87 | $252,617.05 | New | - | - | |
| Jun 26, 2019 | ABBV Abbvie Inc. | Director | Buy | 7,500 | $67.30 | $504,750.00 | +32.4% | - | - | |
| Jun 20, 2018 | ABBV Abbvie Inc. | Director | Buy | 1,013 | $98.63 | $99,908.75 | +5.1% | - | - | |
| Jul 31, 2017 | ABBV Abbvie Inc. | Director | Buy | 4,000 | $70.45 | $281,782.00 | +34.8% | - | - |